PURPOSE: To describe the visual recovery after intravitreal injections of the antivascular endothelial growth factor, bevacizumab, in a case of vaso obliteration from idiopathic @entity4816 , @entity439 , and @entity2479 (IRVAN). The name IRVAN was given to the condition to highlight the key findings present in the disease. IRVAN is a severe, sight threatening condition that can lead to peripheral capillary non-perfusion and vision loss from the ischemic sequelae of @entity432 . Panretinal photocoagulation (PRP) is the current standard of care for IRVAN but visual outcome is poor if PRP is initiated after @entity2295 develops. Intravitreal bevacizumab has success at treating @entity2295 from other @entity63 and inflammatory retinal conditions that have similar characteristics to IRVAN. CASE REPORT: This case report describes a @entity1 with @entity227 in the @entity3012 . The @entity1 presented with best-corrected visual acuity of 20/20 in the @entity5771 and count fingers at 4 ft in the @entity3012 . Evaluation revealed findings consistent with an advanced stage of IRVAN. Anterior and posterior @entity2295 had developed from extensive capillary non-perfusion in both retinas. A dense vitreous @entity548 @entity3012 . Bilateral intravitreal injections of bevacizumab and extensive PRP were given in the area of @entity2479 for treatment. After 4 months, the @entity1 's vision had improved from count fingers in the @entity3012 to 20/40. CONCLUSIONS: IRVAN has favorable outcomes when treated with a combination of PRP and intravitreal injections of antivascular endothelial growth factor. This case demonstrates the effectiveness of this combination treatment in a case of IRVAN with both posterior and anterior @entity2295 .

Visual acuity recovery in a case of idiopathic XXXX and @entity2479 .

@entity1 :: ('9606', 'Species') :: ['patient'] @entity227 :: ('MESH:D014786', 'Disease') :: ['decreased vision'] @entity548 :: ('MESH:D006470', 'Disease') :: ['hemorrhage blocked vision'] @entity2479 :: ('MESH:D012173', 'Disease') :: ['neuroretinitis', 'retinal ischemia'] @entity63 :: ('MESH:D007511', 'Disease') :: ['ischemic retinopathies'] @entity3012 :: ('MESH:C567932', 'Disease') :: ['OS'] @entity2295 :: ('MESH:D015861', 'Disease') :: ['neovascularization'] @entity439 :: ('MESH:D000783', 'Disease') :: ['aneurysm'] @entity432 :: ('MESH:D001157', 'Disease') :: ['vascular occlusion'] @entity5771 :: ('OMIM:165800', 'Disease') :: ['OD'] @entity4816 :: ('MESH:D031300', 'Disease') :: ['retinal vasculitis']
@entity4816 :: (MESH:D031300,Disease) :: ['retinal vasculitis aneurysms']
